Private giants & exposure vehicles

The chokepoint, one week after it cracked open

For three years the densest concentration of quantum-computing value sat in four private cap tables: Quantinuum, PsiQuantum, SandboxAQ, and QuEra. That changed on June 4, 2026, when Quantinuum — valued at $10B pre-money as recently as last September — began trading on Nasdaq as QNT after an upsized IPO: 28 million shares at $60 for $1.68B gross, with Honeywell retaining roughly 48% of voting power (the oft-quoted 49.1% is the filing-stage figure, computed before the offering was upsized). The marquee private giant just became the public market's only heavyweight pure-play, and every other name in this chokepoint now reprices off its tape.

The moat is ownership, not technology alone. NVIDIA's NVentures sits on all four cap tables — Quantinuum's $600M round, PsiQuantum's $1B Series E (co-led by BlackRock-managed funds, Temasek and Baillie Gifford at a $7B valuation), SandboxAQ's $450M Series E at $5.75B alongside Google, and QuEra's expanded financing, which it joined in September 2025. Google and SoftBank Vision Fund 2 came into QuEra's $230M+ convertible financing as new investors (no lead was disclosed — TechCrunch corrected its initial report that Google led). These are not passive positions: they bundle GPU co-design (NVIDIA's accelerated quantum research center counts Quantinuum as a founding collaborator), anchor customer-investors (JPMorganChase in Quantinuum), and state-scale offtake (PsiQuantum's Brisbane and Chicago utility-scale builds). Rounds of $600M–$1B are simply not raisable by the listed quantum small-caps, and DARPA's QBI Stage B selection of Quantinuum and QuEra among 11 teams layers non-dilutive government validation on top.

Breaking the choke requires either a sovereign-scale balance sheet or an architecture leapfrog — both visible on the QBI roster (IBM, IonQ, Xanadu, Atom Computing). The subtler crack is the wrapper story: the retail "exposure vehicles" marketed as back doors — DXYZ, XOVR, Fundrise's VCX, ARK Venture — disclose zero holdings in any of these four companies; their private sleeves are SpaceX and AI labs. The only verifiable listed paths into this chokepoint are the strategics themselves (HON, GOOGL, NVDA) and, since last week, QNT directly.

Be honest about scale: Quantinuum's prospectus showed 2025 revenue of $30.9M against a $192.6M net loss — call it 400x+ trailing sales at the IPO mark — and QuEra declined to disclose a valuation on its convertible note (the ~$400M figure in circulation is a reporter's conservative guess, not a priced mark). The chokepoint (talent density, IP, strategic lock-in, government design wins) is real; the revenue is not yet.

What forces the next repricing: Honeywell's Q2 print updates the monetization path for its ~48% stake mid-breakup; DARPA's Stage C downselect around year-end either blesses or breaks two of the four architectures; and the National Quantum Initiative Reauthorization — already through committee in both chambers — would lock in federal demand through 2034. Watch QNT's tape into Q2B Chicago in December: that is when the public market tells you what the private giants are actually worth.